Devices to Assess Concussions Cleared by FDA

Two devices that help assess a patient’s function following a suspected concussion or other brain injury have received approval for marketing from the U.S. Food and Drug Administration. The devices, the Immediate Post-Concussion Assessment and Cognitive Testing, or ImPACT, and ImPACT Pediatric, are intended to assess cognitive function following a possible concussion, the FDA said in a news release last week. The devices are produced by ImPACT Applications Inc. in Pittsburgh. The devices are designed to test cognitive skills such as word memory, reaction time and word recognition, all ...